ELEVARA MEDICINES LIMITED
Research and experimental development on biotechnology
ELEVARA MEDICINES LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom
Full company profile for ELEVARA MEDICINES LIMITED (16200589), an active company based in Altrincham, United Kingdom. Incorporated 22 Jan 2025. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Financial History
Revenue, profit, EBITDA and key financial figures
No Financial Data Available
Financial information will appear here once available.
Funding
Fundraising & Grants
Investors (2)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Oct 2025 | Series A |
| Investor 2 | Oct 2025 | Series A |
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Emma Jayne Tinsley | Director | British | United Kingdom | 31 Mar 2025 | Active |
| Oakwood Corporate Secretary Limited | Corporate-secretary | United Kingdom | Unknown | 2 Apr 2025 | Active |
| Van Den Brink, Gijs Robert | Director | Dutch | Netherlands | 14 Nov 2025 | Active |
See all 6 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (3)
Emma Jayne Tinsley
British
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Aeon 5 Limited
United Kingdom
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Weatherden Limited
United Kingdom
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Group Structure
Group Structure
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 25 Mar 2026 | Mortgage | Mortgage Create With Deed With Charge Number Charge Creation Date | |
| 3 Feb 2026 | Confirmation Statement | Confirmation statement made on 2026-01-13 with updates | |
| 17 Nov 2025 | Officers | Appointment of Gijs Robert Van Den Brink as director on 2025-11-14 | |
| 14 Nov 2025 | Capital | Capital Name Of Class Of Shares | |
| 14 Nov 2025 | Capital | Capital Variation Of Rights Attached To Shares |
Mortgage Create With Deed With Charge Number Charge Creation Date
Confirmation statement made on 2026-01-13 with updates
Appointment of Gijs Robert Van Den Brink as director on 2025-11-14
Capital Name Of Class Of Shares
Capital Variation Of Rights Attached To Shares
Recent Activity
Latest Activity
Mortgage Create With Deed With Charge Number Charge Creation Date
3 weeks ago on 25 Mar 2026
Confirmation statement made on 2026-01-13 with updates
2 months ago on 3 Feb 2026
Appointment of Gijs Robert Van Den Brink as director on 2025-11-14
5 months ago on 17 Nov 2025
Capital Name Of Class Of Shares
5 months ago on 14 Nov 2025
Capital Variation Of Rights Attached To Shares
5 months ago on 14 Nov 2025